Scadden David bought AGIO
July 10, 2025 · Form 4 insider transaction
Scadden David bought 1,400 shares of Agios Pharmaceuticals, Inc. at $18.09 per share, a transaction worth $25.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,400
Price
$18.09
Total value
$25.3K
InsiderScadden David
Role—
SecurityCommon stock
Transaction codeM: Option exercise
Transaction dateJuly 10, 2025
Filing dateJuly 15, 2025
Shares owned after19,003
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.